BBOT Stock Analysis: Buy, Sell, or Hold?
BBOT - BridgeBio Oncology Therapeutics, Inc. Common Stock
$11.72
-0.78 (-6.24%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 11, 2026
10d
Get Alerted When BBOT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BBOT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BBOT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BBOT is currently trading at $11.72, which is considered slightly low relative to its 30-day fair value range of $11.55 to $12.83.
Technical Outlook: Technically, BBOT is in a uptrend. Immediate support is located at $10.88, while resistance sits at $13.99. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: BBOT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.20 (+93.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BBOT is in a uptrend. Immediate support is located at $10.88, while resistance sits at $13.99. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: BBOT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.20 (+93.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$11.55 -
$12.83
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
Protect Your Profits
Holding BBOT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.2%)
- BULLISH: Trading 93.6% below Wall St target ($24.20)
- CAUTION: Recommendation downgraded due to -7.1% 5-day decline
Fair Price Analysis
30-Day Fair Range
$11.55 -
$12.83
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$10.88
Resistance Level
$13.99
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-6.10
Wall Street Target
$24.20
(+93.6%)
Last updated: January 31, 2026 10:21 AM ET
Data refreshes hourly during market hours. Next update: 11:21 AM
Data refreshes hourly during market hours. Next update: 11:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBOT showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$90 | 59 HOLD |
Advanced BBOT Option Strategies
Professional options setups generated by AI based on today's BBOT price and gamma walls.
